Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer

Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer

Objectives: The effects of first-line chemotherapy on overall survival (OS) might be confounded by subsequent therapies in patients with small cell lung cancer (SCLC). We examined whether progression-free survival (PFS), post-progression survival (PPS), and tumor response could be valid surrogate en...

Full description

Bibliographic Details
Main Authors: Hisao Imai, Keita Mori, Kazushige Wakuda, Akira Ono, Hiroaki Akamatsu, Takehito Shukuya, Tetsuhiko Taira, Hirotsugu Kenmotsu, Tateaki Naito, Kyoichi Kaira, Haruyasu Murakami, Masahiro Endo, Takashi Nakajima, Nobuyuki Yamamoto, Toshiaki Takahashi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Annals of Thoracic Medicine
Subjects:
Extensive small cell lung cancer
overall survival
post-progression survival
progression-free survival
tumor response
Online Access:http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2015;volume=10;issue=1;spage=61;epage=66;aulast=Imai

Internet

http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2015;volume=10;issue=1;spage=61;epage=66;aulast=Imai

Similar Items